Follow us on:
Dedication / Services
To provide 50000 services and products to global scientific research units every year

Demcizumab

DESCRIPTION CATALOG # SIZE PRICE
Anti-Human DLL4 Therapeutic Antibody TAB-204 1mg Please Inquiry
Product Detail
Cat
TAB-204
Product Overview
Recombinant monoclonal antibody to DLL4. Demcizumab is a humanized monoclonal antibody designed for the treatment of cancer.
Target
DLL4
Type
IgG2 - kappa
Immunogen
Partial recombinant DLL4 ragment.
Species Reactivity
Human
Expression Host
CHO
Applications
Suitable for use in ELISA, FC, IP, FuncS, IF, Neut, WB and most other immunological methods.
CAS
1243262-17-0
Specificity
Tested positive against native human antigen.
Protein Construction
Immunoglobulin G2-kappa, anti-[Homo sapiens DLL4 (delta-like 4)], humanized monoclonal antibody; gamma2 heavy chain (1-444) disulfide with kappa light chain (1"-218") dimer.
Predicted N terminal
H chain: QVQLVQS; L chain: DIVMTQS
Molecular Weight
145300
Purity
>97%, by SDS-PAGE under reducing conditions and visualized by silver stain.
Size
1mg
Storage
Store the antibody (in aliquots) at -20°C. Avoid repeated freezing and thawing of samples.
Background
Antigen Description
Plays a role in the Notch signaling pathway. Activates Notch-1 and Notch-4.
Function
Notch binding; calcium ion binding;
Gene ID
54567
Synonyms
DLL4; delta-like 4 (Drosophila); delta like 4 homolog (Drosophila); delta-like protein 4; delta4; delta 4; delta ligand 4; notch ligand DLL4; delta-like 4 homolog; delta-like 4 protein; notch ligand delta-2; drosophila Delta homolog 4; hdelta2; MGC126344;
Download Datasheet:

Our customer service representatives are available 24 hours a day, from Monday to Sunday. Contact Us

Online Inquiry
Please input "biolabs"(case insensitive) as verification code.
Loading...
Contact Us

USA
Tel: 1-631-871-5806
Fax: 1-631-207-8356
Email: 

Europe
Tel: 44-207-097-1828


© 2007 - 2017 Creative-Biolabs All Rights Reserved